Publication | Closed Access

N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseImmunologyOsteoarthritisAutoimmunityTgm2 Mrna ContributesInflammatory Rheumatic DiseaseMedicineCell BiologyInhibitory ActivityRheumatoid ArthritisN6-methyladenosine Modification